Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 189
Selected: 0
NCT IDTitle
NCT00914147Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
NCT01416961Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT00004003Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
NCT02372877Evaluation of the AMICUS RBCx System in Sickle Cell Patients
NCT00011973Chemotherapy in Treating Patients With Advanced Kidney Cancer
NCT00301808Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT00903214Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00691015Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
NCT03875053Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer
NCT00027807Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT07436078Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT00268255Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT02145078Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
NCT00217581Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
NCT02178436Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer
NCT07098299Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
NCT04159896ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
NCT01643603Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
NCT00004024Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
NCT05025748Ask Questions (ASQ):Implementation of a Communication Intervention
NCT00003626Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00872677Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
NCT00520767Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
NCT03453489AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT01208662Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
NCT00288028Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
NCT00243048Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT00499694Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
NCT00002908Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00248560Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
NCT00890617Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis
NCT01468532Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01147016Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
NCT00016185Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
NCT01609816Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
NCT00897910Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
NCT03750981C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
NCT00541099Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT07343297Ask Questions About Clinical Trials
NCT07130903Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
NCT00972023DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
NCT00244946Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
NCT00717535Studying Umbilical Cord Blood From African-American Donors
NCT03252600Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
NCT07218432A Study of the TheraBionic P1 Device in Breast Cancer
NCT01022138Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
NCT00244933Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer